Cyclo Therapeutics, Inc. CYTH
0.72 0.00 (+0.00%)
At closeMar 26, 2025, 4:00 PM EDT
0.7206 Day range 0.7206
52-week range unavailable
- YTD
- +22.14%
- 1 year
- -49.61%
Analyst view
Price target (mean) 0.95
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 322.00K | +3.4% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 150.00K | -25.9% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 966.33K | -10.2% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 1.20M | +24.5% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 27, 2024 | Maxim Group | Downgrade | Buy | Hold |
| Aug 26, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Aug 23, 2024 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Aug 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 31, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 1, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Apr 22, 2024 | Ascendiant Capital | Initiated | — | Buy |
| Sep 27, 2023 | Maxim Group | Upgrade | Hold | Buy |
| Mar 21, 2023 | Maxim Group | Downgrade | Buy | Hold |
| Dec 17, 2020 | Maxim Group | Initiated | — | Buy |